Evidence map›Paper›PMID 39279928›Full record

ArticleJournal of gastrointestinal oncology2024

Integrated molecular profiling of

Gabriela Remonatto, Emily Ferreira Salles Pilar, Fernanda de-Paris, Pedro Guilherme Schaefer, Lúcia Maria Kliemann

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Molecular identification ofMolecular biology research communications · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabriela RemonattoPathology Service, Hospital de Clínicas de Porto Alegre, RS, Brazil.ORCID https://orcid.org/0000-0001-6150-9407
Emily Ferreira Salles PilarLaboratory Research Unit, Hospital de Clínicas de Porto Alegre, RS, Brazil.ORCID https://orcid.org/0000-0003-3417-3586
Fernanda de-ParisTransplant and Personalized Medicine Unit of the Laboratory Diagnostic Service, Hospital de Clínicas de Porto Alegre, RS, Brazil.ORCID https://orcid.org/0000-0003-2563-9487
Pedro Guilherme SchaeferPathology Service, Hospital de Clínicas de Porto Alegre, RS, Brazil.ORCID https://orcid.org/0000-0003-2792-6586
Lúcia Maria KliemannPathology Service, Hospital de Clínicas de Porto Alegre, RS, Brazil.ORCID https://orcid.org/0000-0001-7249-7800

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal carcinoma (CRC) is one of the most frequently diagnosed forms of cancer worldwide. The Methods: A cross-sectional retrospective study was carried out, where molecular analysis of mutations in the Results: Next-generation sequencing (NGS) analysis of 310 tumors revealed that 202 patients (65.2%) had mutations. The Conclusions: Deficiency in the MMR system is associated with the presence of the

Indexed as

BRAFColorectal carcinoma (CRC)KRASmismatch repair (MMR)NRAS

Identifiers

PMID39279928
PMCPMC11399832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.